Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT.
Nathanael KaneTahmineh RomeroSilvia Diaz-PerezMatthew B RettigMichael L SteinbergAmar U KishanDörthe SchaueRobert E ReiterBeatrice S KnudsenNicholas G NickolsPublished in: Prostate cancer and prostatic diseases (2022)
Two weeks after SBRT, CD68, and CD163 macrophages are significantly increased while CD8 T cells are decreased. SBRT markedly alters the immune environment within prostate cancers.